Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
advanceCor GmbH logo — Biotech company independent development of innovative drugs...

advanceCor GmbH

Biotech company independent development of innovative drugs + diagnostics for heart disease, cardiology

Founded 2012 Germany Germany 5 employees Unknown Total: $3.90M Biotechnology

General Information

Company Name advanceCor GmbH
Founded Year 2012
Location Germany Germany +1
Employees 5
Industries Biotechnology
Funding Stage Unknown
Social

Get notified when advanceCor GmbH moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About advanceCor GmbH

advanceCOR GmbH is a pioneering clinical drug development company founded in 2012, specializing in therapeutics and diagnostics for cardiovascular diseases. The company's products, including Revacept, COR-2, and COR-3, demonstrate innovative approaches to preventing platelet activation, interfering with foam cell formation, and accelerating plaque healing. With a focus on biotechnology, advanceCOR attained a significant milestone with a €6.00M Venture Round investment on 21 May 2018, garnering support from prominent investors such as Bayern Kapital, KfW, MIG AG, Occident, and HTGF | High-Tech Gruenderfonds. The company's extensive portfolio and strategic investments position advanceCOR as a key player in advancing solutions for heart and vascular health.

Taxonomy: clinical drug development, therapeutics, diagnostics, cardiovascular diseases, Revacept, COR-2, COR-3, therapeutic advancements, vascular health, heart health, platelet activation, atherosclerotic plaques, foam cell formation, progenitor cell therapy

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Late Vc •••••• 5
Investor Investor Investor Investor Investor
01 Jun 2020
Grant •••••• - 01 May 2019

advanceCor GmbH Alternatives & Competitors

advanceCor GmbH vs
Cleave Therapeutics, Inc.
Cleave Therapeutics, Inc. United States

VCP/p97 Inhibitors for Oncology and Neurodegenerative Diseases

Series C
3 employees
Biopharma, Biotechnology

FAQ About advanceCor GmbH

Biotech company independent development of innovative drugs + diagnostics for heart disease, cardiology
advanceCor GmbH was founded in 2012.
advanceCor GmbH is headquartered in Germany.
advanceCor GmbH operates in the following industries: Biotechnology.
advanceCor GmbH has approximately 5 employees.
advanceCor GmbH has completed 2 funding rounds, raising a total of $3.90M. The latest funding stage is Unknown.
Top alternatives and competitors to advanceCor GmbH include Cleave Therapeutics, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
advanceCor GmbH and Cleave Therapeutics, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors advanceCor GmbH and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy